Sort   by:  
 Page size 
TranscriptomicsGene expression profiling in true interval breast cancer reveals overactivation of mTOR signalling pathway
Background: Interval breast cancers can occur through failure to detect an abnormality at the time of screening (missed interval cancer), or as a new event after a negative screen (true interval cancer). The development and progression of true interval tumors (TIBC) is known to be different than scr...
ORGANISM(S): Homo sapiens 
2013-12-23 | E-GEOD-47108 | biostudies-arrayexpress
TranscriptomicsDeficiency in tumor suppressor p53 is required for doxorubicin induced transcriptional upregulation of NF-kB target genes in human breast cancer
NF-kB has been linked to doxorubicin-based chemotherapy resistance in breast cancer patients. NF-kB nuclear translocation and DNA binding in doxorubicin treated-breast cancer cells have been extensively examined, however its functional consequences in terms the spectrum of NF-kB -dependent genes exp...
ORGANISM(S): Homo sapiens 
2013-12-31 | E-GEOD-47013 | biostudies-arrayexpress
TranscriptomicsDUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small cell lung cancer
DUSP1 is involved in different cellular pathways including cancer cell proliferation, angiogenesis, invasion and resistance to chemotherapy. To understand more about the cellular responses regulated by DUSP1 in NSCLC cells, we interfered DUSP1 expression in the NSCLC cell line H460 and studied the c...
ORGANISM(S): Homo sapiens 
2010-12-09 | E-GEOD-19592 | biostudies-arrayexpress
UnknownDeficiency in tumor suppressor p53 is required for doxorubicin induced transcriptional upregulation of NF-kB target genes in human breast cancer
Not available
ORGANISM(S): Homo sapiens 
S-ECPF-GEOD-47013 | biostudies-other
UnknownPrimary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study.
Not available
S-EPMC7211017 | biostudies-literature
UnknownOlaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study.
Not available
S-EPMC11362778 | biostudies-literature
UnknownNeoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score ≥18: DxCARTES study.
Not available
S-EPMC11472226 | biostudies-literature
UnknownMammalian CDC14 phosphatases control exit from stemness in pluripotent cells
Not available
S-SCDT-EMBOJ-2022-111251 | biostudies-other
UnknownThe onset of PI3K-related vascular malformations occurs during angiogenesis
Not available
S-SCDT-EMM-2021-15619 | biostudies-other
UnknownHistamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis
Not available
S-SCDT-EMM-2021-13929 | biostudies-other
Sort   by:  
 Page size